CELG.RT
Citadel Advisors’s Bristol-Myers Squibb Company Contingent Value Rights CELG.RT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $885 | Sell |
35,388
-1,534
| -4% | -$38 | ﹤0.01% | 5721 |
|
|
2025
Q1 | $1.85K | Buy |
+36,922
| New | +$1.85K | ﹤0.01% | 5771 |
|
|
2024
Q4 | – | Sell |
-37,572
| Closed | -$1.8K | – | 6056 |
|
|
2024
Q3 | $1.8K | Sell |
37,572
-332
| -0.9% | -$16 | ﹤0.01% | 5590 |
|
|
2024
Q2 | $1.55K | Sell |
37,904
-130
| -0.3% | -$5 | ﹤0.01% | 5678 |
|
|
2024
Q1 | $2.09K | Sell |
38,034
-679
| -2% | -$37 | ﹤0.01% | 5864 |
|
|
2023
Q4 | $3.48K | Sell |
38,713
-2,001
| -5% | -$180 | ﹤0.01% | 5640 |
|
|
2023
Q3 | $3.87K | Sell |
40,714
-282
| -0.7% | -$27 | ﹤0.01% | 5549 |
|
|
2023
Q2 | $4.51K | Sell |
40,996
-1,333
| -3% | -$147 | ﹤0.01% | 5471 |
|
|
2023
Q1 | $5.33K | Buy |
42,329
+5,192
| +14% | +$654 | ﹤0.01% | 5601 |
|
|
2022
Q4 | $4.38K | Sell |
37,137
-142
| -0.4% | -$17 | ﹤0.01% | 5805 |
|
|
2022
Q3 | $5K | Sell |
37,279
-675
| -2% | -$91 | ﹤0.01% | 5701 |
|
|
2022
Q2 | $5K | Sell |
37,954
-87,142
| -70% | -$11.5K | ﹤0.01% | 5870 |
|
|
2022
Q1 | $19K | Sell |
125,096
-86,129
| -41% | -$13.1K | ﹤0.01% | 6142 |
|
|
2021
Q4 | $40K | Buy |
211,225
+1,158
| +0.6% | +$219 | ﹤0.01% | 6210 |
|
|
2021
Q3 | $46K | Sell |
210,067
-4,984
| -2% | -$1.09K | ﹤0.01% | 6139 |
|
|
2021
Q2 | $52K | Buy |
+215,051
| New | +$52K | ﹤0.01% | 6192 |
|
|
2020
Q4 | – | Sell |
-20,251
| Closed | -$8K | – | 5099 |
|
|
2020
Q3 | $8K | Buy |
+20,251
| New | +$8K | ﹤0.01% | 4584 |
|
|
2020
Q2 | – | Sell |
-12,482
| Closed | -$6K | – | 4689 |
|
|
2020
Q1 | $6K | Buy |
+12,482
| New | +$6K | ﹤0.01% | 4769 |
|